Table 2.
classes of antibiotic prescribed among hospitalized patients based on the indications
| Classes of antibiotic | Frequency (%) | |||||
|---|---|---|---|---|---|---|
| Total | CI | HI | SP | MP | UI | |
| Nitroimidazoles | 128 (28.5) | 46 (26.4) | 23 (31.5) | 34 (33.7) | 13 (19.4) | 12 (35.3) |
| Third generation cephalosporins | 85 (18.9) | 26 (14.9) | 15 (20.5) | 21 (20.8) | 16 (23.9) | 7 (20.6) |
| Fluoroquinolones | 61 (13.6) | 33 (19.0) | 8 (11.0) | 8 (7.9) | 5 (7.5) | 7 (20.6) |
| Penicillins – beta lactamase inhibitors | 47 (10.5) | 18 (10.3) | 8 (11.0) | 11 (10.9) | 7 (10.4) | 3 (8.8) |
| Aminoglycosides | 38 (8.5) | 13 (7.5) | 10 (13.7) | 4 (4.0) | 10 (14.9) | 1 (2.9) |
| Penicillins | 38 (8.5) | 11 (6.3) | 4 (5.5) | 8 (7.9) | 12 (17.9) | 3 (8.8) |
| Second generation cephalosporins | 17 (3.8) | 6 (3.4) | 2 (2.7) | 9 (8.9) | 0 (0.0) | 0 (0.0) |
| Lincosamides | 14 (3.1) | 9 (5.2) | 1 (1.4) | 3 (3.0) | 1 (1.5) | 0 (0.0) |
| Macrolides | 8 (1.8) | 6 (3.4) | 0 (0.0) | 1 (1.0) | 1 (1.5) | 0 (0.0) |
| Sulphonamides | 4 (0.9) | 2 (1.1) | 1 (1.4) | 0 (0.0) | 1 (1.5) | 0 (0.0) |
| Tetracyclines | 4 (0.9) | 1 (0.6) | 0 (0.0) | 2 (2.0) | 0 (0.0) | 1 (2.9) |
| Amphenicols | 3 (0.7) | 3 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Carbapenems | 1 (0.2) | 0 (0.0) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Nitrofuran derivatives | 1 (0.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.5) | 0 (0.0) |
| Proportion of broad spectrum antibiotics | 147 (32.7) | 59 (33.9) | 32 (43.8) | 42 (41.6) | 21 (31.3) | 14 (41.2) |
CI Community acquired infections, HI Hospital acquired infections, SP Surgical prophylaxis, MP Medical prophylaxis and UI Unknown indication